Suini tablets 100mg, manufactured by Sanwa Chemical Laboratory, contain Anagliptin, a DPP-4 inhibitor primarily used to improve glycemic control in adults with type 2 diabetes. This medication is a 100mg 1 tablet with YJ code 3969016F1023.
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
This website contains information intended for healthcare professionals, including physicians, pharmacists, and other medical staff.
Please confirm that you are a healthcare professional before continuing.
* Your selection will be saved on this device and will not be asked again for a certain period.